Literature DB >> 14507967

Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration.

Hongxin Dong1, Alicia Fazzaro, Chuanxi Xiang, Stanley J Korsmeyer, Mark F Jacquin, John W McDonald.   

Abstract

Mechanisms of oligodendrocyte death after spinal cord injury (SCI) were evaluated by T9 cord level hemisection in wild-type mice (C57BL/6J and Bax+/+ mice), Wlds mice in which severed axons remain viable for 2 weeks, and mice deficient in the proapoptotic protein Bax (Bax-/-). In the lateral white-matter tracts, substantial oligodendrocyte death was evident in the ipsilateral white matter 3-7 mm rostral and caudal to the hemisection site 8 d after injury. Ultrastructural analysis and expression of anti-activated caspase-3 characterized the ongoing oligodendrocyte death at 8 d as primarily apoptotic. Oligodendrocytes were selectively preserved in Wlds mice compared with C57BL/6J mice at 8 d after injury, when severed axons remained viable as verified by antereograde labeling of the lateral vestibular spinal tract. However, 30 d after injury when the severed axons in Wlds animals were already degenerated, the oligodendrocytes preserved at 8 d were lost, and numbers were then equivalent to control C57BL/6J mice. In contrast, oligodendrocyte death was prevented at both time points in Bax-/- mice. When cultured oligodendrocytes were exposed to staurosporine or cyclosporin A, drugs known to stimulate apoptosis in oligodendrocytes, those from Bax-/- mice but not from Bax+/+ or Bax+/- mice were resistant to the apoptotic death. In contrast, the three groups were equally vulnerable to excitotoxic necrosis death induced by kainate. On the basis of these data, we hypothesize that the Wallerian degeneration of white matter axons that follows SCI removes axonal support and induces apoptotic death in oligodendrocytes by triggering Bax expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507967      PMCID: PMC6740425     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.

Authors:  M Xie; Q Wang; T-H Wu; S-K Song; S-W Sun
Journal:  Neuroscience       Date:  2011-09-25       Impact factor: 3.590

3.  Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+.

Authors:  Christian T Sheline; Ai-Li Cai; Julia Zhu; Chunxiao Shi
Journal:  Eur J Neurosci       Date:  2010-08-16       Impact factor: 3.386

Review 4.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 5.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

6.  Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury.

Authors:  Chad S Siegel; Kathren L Fink; Stephen M Strittmatter; William B J Cafferty
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

7.  Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice.

Authors:  Wesley A Hendricks; Elena S Pak; J Paul Owensby; Kristie J Menta; Margarita Glazova; Justin Moretto; Sarah Hollis; Kori L Brewer; Alexander K Murashov
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

8.  Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.

Authors:  Emanuela Esposito; Stefano Bruscoli; Emanuela Mazzon; Irene Paterniti; Maddalena Coppo; Enrico Velardi; Salvatore Cuzzocrea; Carlo Riccardi
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

9.  KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice.

Authors:  Marika Cordaro; Irene Paterniti; Rosalba Siracusa; Daniela Impellizzeri; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2016-03-10       Impact factor: 5.590

10.  IL-10 promotes neuronal survival following spinal cord injury.

Authors:  Zhigang Zhou; Xiangmin Peng; Ryan Insolera; David J Fink; Marina Mata
Journal:  Exp Neurol       Date:  2009-08-27       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.